Scholl Hendrik Peter
SEC CIK 2113223 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BLTE | BELITE BIO, INC | Chief Medical Off | 15.0K | — | $2.86M | 2 | 2026-06-16 | 2026-06-18 |
Most active insiders at BLTE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Yu-Hsin | CEO, Dir | — | $20.82M |
| 2 | Chuang Hao-Yuan | CFO, Dir | — | $14.00M |
| 3 | Scholl Hendrik Peter | Chief Medical Off | — | $2.86M |
| 4 | MATA NATHAN L. | CSO | — | $2.67M |
| 5 | Chen Wan-Shan | Dir | — | $198.5K |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-06-22 06:05 | 2026-06-18 | BLTE | BELITE BIO, INC | Scholl Hendrik Peter | Chief Medical Off | S - Sale | $145.24 | -10.0K | 15.0K | -40% | -$1.45M |
| MI | 2026-06-17 06:03 | 2026-06-16 | BLTE | BELITE BIO, INC | Scholl Hendrik Peter | Chief Medical Off | S - Sale | $140.57 | -10.0K | 25.0K | -29% | -$1.41M |
Purchase Sale Sale after option exercise All abbreviations